Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Radiotherapy
- Small Cell Lung Cancer Limited Stage
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Three hundred and twenty-six patients with a histological or cytological proven diagnosis of SCLC will be recruited from 35 centers in 14 areas including provinces, municipalities and autonomous region, from May 2017 to May 2020.
Three hundred and twenty-six patients with a histological or cytological proven diagnosis of SCLC will be recruited from 35 centers in 14 areas including provinces, municipalities and autonomous region, from May 2017 to May 2020.
Tracking Information
- NCT #
- NCT03214003
- Collaborators
- Sun Yat-sen University
- Fudan University
- Xijing Hospital
- Henan Cancer Hospital
- Jilin Provincial Tumor Hospital
- Peking University First Hospital
- Beijing Chao Yang Hospital
- First Affiliated Hospital of Xinjiang Medical University
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Air Force General Hospital of the PLA
- China-Japan Friendship Hospital
- Peking University People's Hospital
- Peking University Third Hospital
- Beijing Hospital
- Peking Union Medical College Hospital
- Investigators
- Principal Investigator: Anhui Shi, Doctor Beijing Cancer Hospital
Get Well Soon